Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
In clinical trials, people lost an average of 9.4% to 14.7% of their body weight over 40 weeks
Statements Author contributions NI wrote the manuscript and prepared the figures
Sub-therapeutic Risk : The risk of underdosing, especially with TB-500, is significant
What science actually says Clinically reviewed by Dr
USA 102 , 1018810193 (2005)
Clinical Efficacy of Tesofensine Clinical trials investigating tesofensine's efficacy in weight loss have provided encouraging results, solidifying its position as a potential frontrunner in obesity treatment
US$ 25.57
US$ 20.56
US$ 25.45
US$ 27.19
US$ 20.52
